Initiating therapy or switching to biphasic insulin aspart improves glycaemic control in type 2 diabetes: an Indian experience from the A1chieve study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Association of Physicians of India

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 24482982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for insulin initiation based on ethnicity.

  2011cited by this paper
• An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study.

  2011cited by this paper
• Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes

  2011cited by this paper
• Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring

  2011cited by this paper
• The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm

  2010cited by this paper
• Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs.

  2010cited by this paper
• Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.

  2009cited by this paper
• Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

  2009cited by this paper
• Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses

  2009cited by this paper
• Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix® 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

  2009cited by this paper
• Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study

  2008cited by this paper
• Postprandial hyperglycemia and diabetes complications: is it time to treat?

  2005cited by this paper
• Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

  2003cited by this paper
• Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.

  1988cited by this paper

• The impact of multiple lifestyle interventions on remission of type 2 diabetes mellitus within a clinical setting

  2019cites this paper
• Short Term Efficacy and Safety of Insulin Glargine in Type 2 Diabetes Inadequately Controlled with Single or Two Oral Agents: A Prospective, Open Label Study.

  2017cites this paper
• An Audit of Insulin Usage and Insulin Injection Practices in a Large Indian Cohort

  2017cites this paper
• Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature

  2016cites this paper
• Clinical experience of switching from biphasic human insulin to biphasic insulin aspart 30 in Indian patients with type 2 diabetes in the A1chieve study

  2015cites this paper
• Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis

  2015cites this paper